Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes: The TODAY clinical trial

OBJECTIVE: Type 2 diabetes increases cardiovascular risk. We examined lipid profiles and inflammatory markers in 699 youth with recent-onset type 2 diabetes in the TODAY clinical trial and compared changes across treatment groups: metformin alone (M), metformin plus rosiglitazone (M+R), and metformi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661790/
https://www.ncbi.nlm.nih.gov/pubmed/23704675
http://dx.doi.org/10.2337/dc12-2388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661790/
https://www.ncbi.nlm.nih.gov/pubmed/23704675
http://dx.doi.org/10.2337/dc12-2388

Ejemplares similares